Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy

Yang Li,1,2,* Yanhong Duo,1,3,* Jiangang Bi,1 Xiaowei Zeng,4 Lin Mei,4 Shiyun Bao,1 Lisheng He,5 Aijun Shan,2 Yue Zhang,1 Xiaofang Yu1 1Department of Hepatobiliary and Pancreas Surgery, Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen 518020, China...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Li Y, Duo Y, Bi J, Zeng X, Mei L, Bao S, He L, Shan A, Zhang Y, Yu X
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	miR-155 mesoporous silica nanoparticles AS1411 aptamer NF-κB 5-fluorouracil Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/a6283ed9312b4c448d2e6b890a91fc81
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a6283ed9312b4c448d2e6b890a91fc81
record_format	dspace
spelling	oai:doaj.org-article:a6283ed9312b4c448d2e6b890a91fc812021-12-02T00:58:34ZTargeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy1178-2013https://doaj.org/article/a6283ed9312b4c448d2e6b890a91fc812018-03-01T00:00:00Zhttps://www.dovepress.com/targeted-delivery-of-anti-mir-155-by-functionalized-mesoporous-silica--peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Yang Li,1,2,* Yanhong Duo,1,3,* Jiangang Bi,1 Xiaowei Zeng,4 Lin Mei,4 Shiyun Bao,1 Lisheng He,5 Aijun Shan,2 Yue Zhang,1 Xiaofang Yu1 1Department of Hepatobiliary and Pancreas Surgery, Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen 518020, China; 2Department of Emergency, Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen 518020, China; 3Key Laboratory of Plant Cell Activities and Stress Adaptation, Ministry of Education, School of Life Sciences, Lanzhou University, Lanzhou 730000, China; 4Division of Life and Health Sciences, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518020, China; 5Department of Pathology, Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen 518020, China *These authors contributed equally to this work Introduction: MicroRNA-155 (miR-155) is an oncogenic microRNA, which is upregulated in many human cancers including colorectal cancer (CRC). Overexpression of miR-155 has been found to regulate several cancer-related pathways, and therefore, targeting miR-155 may be an effective strategy for cancer therapy. However, effective and safe delivery of anti-miR-155 to tumors remains challenging for the clinical applications of anti-miR-155-based therapeutics.Methods: In this study, we explored the expression of miR-155 and the transcription factor nuclear factor kappa B (NF-κB) in CRC tissues and cell lines, and the possible relationship between miR-155 and NF-κB. We further report on anti-miR-155-loaded mesoporous silica nanoparticles (MSNs) modified with polymerized dopamine (PDA) and AS1411 aptamer (MSNs-anti-miR-155@PDA-Apt) for the targeted treatment of CRC.Results: Results showed that miR-155 is overexpressed in CRC tissues and cell lines, and there is a positive feedback loop between NF-κB and miR-155. Compared to the control groups, MSNs-anti-miR-155@PDA-Apt could efﬁciently downregulate miR-155 expression in SW480 cells and achieve significantly high targeting efficiency and enhanced therapeutic effects in both in vivo and in vitro experiments. Furthermore, inhibition of miR-155 by MSNs-anti-miR-155@PDA-Apt can enhance the sensitivity of SW480 to 5-fluorouracil chemotherapy.Conclusion: Thus, our results suggested that MSNs-anti-miR-155@PDA-Apt is a promising nanoformulation for CRC treatment. Keywords: miR-155, mesoporous silica nanoparticles, AS1411 aptamer, NF-κB, 5-fluorouracilLi YDuo YBi JZeng XMei LBao SHe LShan AZhang YYu XDove Medical PressarticlemiR-155mesoporous silica nanoparticlesAS1411 aptamerNF-κB5-fluorouracilMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 13, Pp 1241-1256 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	miR-155 mesoporous silica nanoparticles AS1411 aptamer NF-κB 5-fluorouracil Medicine (General) R5-920
spellingShingle	miR-155 mesoporous silica nanoparticles AS1411 aptamer NF-κB 5-fluorouracil Medicine (General) R5-920 Li Y Duo Y Bi J Zeng X Mei L Bao S He L Shan A Zhang Y Yu X Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy
description	Yang Li,1,2,* Yanhong Duo,1,3,* Jiangang Bi,1 Xiaowei Zeng,4 Lin Mei,4 Shiyun Bao,1 Lisheng He,5 Aijun Shan,2 Yue Zhang,1 Xiaofang Yu1 1Department of Hepatobiliary and Pancreas Surgery, Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen 518020, China; 2Department of Emergency, Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen 518020, China; 3Key Laboratory of Plant Cell Activities and Stress Adaptation, Ministry of Education, School of Life Sciences, Lanzhou University, Lanzhou 730000, China; 4Division of Life and Health Sciences, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518020, China; 5Department of Pathology, Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen 518020, China *These authors contributed equally to this work Introduction: MicroRNA-155 (miR-155) is an oncogenic microRNA, which is upregulated in many human cancers including colorectal cancer (CRC). Overexpression of miR-155 has been found to regulate several cancer-related pathways, and therefore, targeting miR-155 may be an effective strategy for cancer therapy. However, effective and safe delivery of anti-miR-155 to tumors remains challenging for the clinical applications of anti-miR-155-based therapeutics.Methods: In this study, we explored the expression of miR-155 and the transcription factor nuclear factor kappa B (NF-κB) in CRC tissues and cell lines, and the possible relationship between miR-155 and NF-κB. We further report on anti-miR-155-loaded mesoporous silica nanoparticles (MSNs) modified with polymerized dopamine (PDA) and AS1411 aptamer (MSNs-anti-miR-155@PDA-Apt) for the targeted treatment of CRC.Results: Results showed that miR-155 is overexpressed in CRC tissues and cell lines, and there is a positive feedback loop between NF-κB and miR-155. Compared to the control groups, MSNs-anti-miR-155@PDA-Apt could efﬁciently downregulate miR-155 expression in SW480 cells and achieve significantly high targeting efficiency and enhanced therapeutic effects in both in vivo and in vitro experiments. Furthermore, inhibition of miR-155 by MSNs-anti-miR-155@PDA-Apt can enhance the sensitivity of SW480 to 5-fluorouracil chemotherapy.Conclusion: Thus, our results suggested that MSNs-anti-miR-155@PDA-Apt is a promising nanoformulation for CRC treatment. Keywords: miR-155, mesoporous silica nanoparticles, AS1411 aptamer, NF-κB, 5-fluorouracil
format	article
author	Li Y Duo Y Bi J Zeng X Mei L Bao S He L Shan A Zhang Y Yu X
author_facet	Li Y Duo Y Bi J Zeng X Mei L Bao S He L Shan A Zhang Y Yu X
author_sort	Li Y
title	Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy
title_short	Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy
title_full	Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy
title_fullStr	Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy
title_full_unstemmed	Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy
title_sort	targeted delivery of anti-mir-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy
publisher	Dove Medical Press
publishDate	2018
url	https://doaj.org/article/a6283ed9312b4c448d2e6b890a91fc81
work_keys_str_mv	AT liy targeteddeliveryofantimir155byfunctionalizedmesoporoussilicananoparticlesforcolorectalcancertherapy AT duoy targeteddeliveryofantimir155byfunctionalizedmesoporoussilicananoparticlesforcolorectalcancertherapy AT bij targeteddeliveryofantimir155byfunctionalizedmesoporoussilicananoparticlesforcolorectalcancertherapy AT zengx targeteddeliveryofantimir155byfunctionalizedmesoporoussilicananoparticlesforcolorectalcancertherapy AT meil targeteddeliveryofantimir155byfunctionalizedmesoporoussilicananoparticlesforcolorectalcancertherapy AT baos targeteddeliveryofantimir155byfunctionalizedmesoporoussilicananoparticlesforcolorectalcancertherapy AT hel targeteddeliveryofantimir155byfunctionalizedmesoporoussilicananoparticlesforcolorectalcancertherapy AT shana targeteddeliveryofantimir155byfunctionalizedmesoporoussilicananoparticlesforcolorectalcancertherapy AT zhangy targeteddeliveryofantimir155byfunctionalizedmesoporoussilicananoparticlesforcolorectalcancertherapy AT yux targeteddeliveryofantimir155byfunctionalizedmesoporoussilicananoparticlesforcolorectalcancertherapy
_version_	1718403401864183808

Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy

Ejemplares similares